Report cover image

Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2025-2033

Publisher IMARC Services Pvt. Ltd.
Published Feb 10, 2025
Length 145 Pages
SKU # IMRC19607502

Description

The Brazil generic drug market size reached USD 22.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.3 Billion by 2033, exhibiting a growth rate (CAGR) of 6.43% during 2025-2033. The Brazil market is primarily driven by growing government support, cost-effectiveness appealing to diverse economic demographics, a growing aging population with escalating healthcare needs, and substantial pharmaceutical investments enhancing local production.

Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years. The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market in the coming years.

The report entitled “Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2025-2033” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.

Key Questions Answered in This Report: How has the Brazil generic drug market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the Brazil generic drug market?
  • What is the impact of each driver, restraint, and opportunity on the Brazil generic drug market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the Brazil generic drug market?

    • Table of Contents

    145 Pages
    1 Preface
    2 Scope and Methodology
    2.1 Objectives of the study
    2.2 Stakeholders
    2.3 Data Sources
    2.3.1 Primary Sources
    2.3.2 Secondary Sources
    2.4 Market Estimation
    2.4.1 Bottom-Up Approach
    2.4.2 Top-Down Approach
    2.5 Forecasting Methodology
    3 Executive Summary
    4 Brazil Generic Drug Market - Introduction
    4.1 What are Generic Drugs?
    4.2 Classification of Generic Drugs
    5 Why is the Brazil Generic Drug Market So Lucrative
    5.1 Drug Patent Expiries
    5.2 Lower Costs
    5.3 Government Support
    5.4 Increasing Consumer Confidence
    5.5 Increasing Access to Generic Drugs
    5.6 High Growth Potential for Biosimilar Drugs
    6 Global Generic Drug Market
    6.1 Generic Drug Market Performance
    6.1.1 Value Trends
    6.1.2 Volume Trends
    6.2 Market Breakup by Country
    6.3 Most Prescribed Generic and Branded Drugs
    6.4 Market Forecast
    7 Brazil Generic Drug Market
    7.1 Brazil Pharmaceutical Market Performance
    7.1.1 Value Trends
    7.1.2 Volume Trends
    7.1.3 Market Breakup by Type
    7.1.4 Market Forecast
    7.2 Brazil Generic Drug Market Performance
    7.2.1 Value Trends
    7.2.2 Volume Trends
    7.2.3 Impact of COVID-19
    7.2.4 Market Forecast
    8 Brazil Generic Drug Industry: SWOT Analysis
    8.1 Overview
    8.2 Strengths
    8.3 Weaknesses
    8.4 Opportunities
    8.5 Threats
    9 Brazil Generic Drug Industry: Value Chain Analysis
    9.1 Research and Development
    9.2 Manufacturing
    9.3 Marketing
    9.4 Distribution
    9.5 Pricing
    10 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain
    11 Brazil Generic Drug Industry: Porter’s Five Forces Analysis
    11.1 Overview
    11.2 Bargaining Power of Buyers
    11.3 Bargaining Power of Suppliers
    11.4 Degree of Competition
    11.5 Threat of New Entrants
    11.6 Threat of Substitutes
    12 Brazil Generic Drug Market: Competitive Landscape
    12.1 Brazil Generic Drug Market: Competitive Structure
    12.2 Brazil Generic Drug Market: Market Share of Key Players
    12.3 Distribution Channels
    13 Government Policy
    14 Brazil Generic Drug Market: Key Success Factors
    15 Brazil Generic Drug Market: Road Blocks
    16 Generic Drug Manufacturing Process
    16.1 Manufacturing Process
    16.2 Raw Material Requirements
    16.3 Raw Materials Pictures
    16.4 Land and Construction Requirements
    16.5 Machinery and Infrastructure Requirements
    16.6 Machinery Pictures
    16.7 Plant Layout
    16.8 Packaging Requirements
    16.9 Utility Requirements
    16.10 Manpower Requirements
    17 Brazil Generic Drug Market: Key Company Profiles

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us